1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Clinical Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Diagnostic Biomarkers
  • 1.2.3 Predictive Biomarkers
  • 1.2.4 Prognostic Biomarkers
• 1.3 Market by Application
  • 1.3.1 Global Clinical Biomarkers Market Share by Application: 2020 VS 2026
  • 1.3.2 Research and Academic Laboratories
  • 1.3.3 Biopharmaceutical and Biotech Companies
  • 1.3.4 Diagnostic Centers
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Clinical Biomarkers Market Perspective (2015-2026)
• 2.2 Global Clinical Biomarkers Growth Trends by Regions
  • 2.2.1 Clinical Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Clinical Biomarkers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Clinical Biomarkers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Clinical Biomarkers Players by Market Size
  • 3.1.1 Global Top Clinical Biomarkers Players by Revenue (2015-2020)
  • 3.1.2 Global Clinical Biomarkers Revenue Market Share by Players (2015-2020)
• 3.2 Global Clinical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Clinical Biomarkers Revenue
• 3.4 Global Clinical Biomarkers Market Concentration Ratio
  • 3.4.1 Global Clinical Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarkers Revenue in 2019
• 3.5 Key Players Clinical Biomarkers Area Served
• 3.6 Key Players Clinical Biomarkers Product Solution and Service
• 3.7 Date of Enter into Clinical Biomarkers Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Biomarkers Breakdown Data by Type (2015-2026)

• 4.1 Global Clinical Biomarkers Historic Market Size by Type (2015-2020)
• 4.2 Global Clinical Biomarkers Forecasted Market Size by Type (2021-2026)

5 Clinical Biomarkers Breakdown Data by Application (2015-2026)

• 5.1 Global Clinical Biomarkers Historic Market Size by Application (2015-2020)
• 5.2 Global Clinical Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Clinical Biomarkers Market Size (2015-2026)
• 6.2 North America Clinical Biomarkers Market Size by Type (2015-2020)
• 6.3 North America Clinical Biomarkers Market Size by Application (2015-2020)
• 6.4 North America Clinical Biomarkers Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Clinical Biomarkers Market Size (2015-2026)
• 7.2 Europe Clinical Biomarkers Market Size by Type (2015-2020)
• 7.3 Europe Clinical Biomarkers Market Size by Application (2015-2020)
• 7.4 Europe Clinical Biomarkers Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Clinical Biomarkers Market Size (2015-2026)
• 8.2 China Clinical Biomarkers Market Size by Type (2015-2020)
• 8.3 China Clinical Biomarkers Market Size by Application (2015-2020)
• 8.4 China Clinical Biomarkers Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Clinical Biomarkers Market Size (2015-2026)
• 9.2 Japan Clinical Biomarkers Market Size by Type (2015-2020)
• 9.3 Japan Clinical Biomarkers Market Size by Application (2015-2020)
• 9.4 Japan Clinical Biomarkers Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Clinical Biomarkers Market Size (2015-2026)
• 10.2 Southeast Asia Clinical Biomarkers Market Size by Type (2015-2020)
• 10.3 Southeast Asia Clinical Biomarkers Market Size by Application (2015-2020)
• 10.4 Southeast Asia Clinical Biomarkers Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Clinical Biomarkers Introduction
  • 11.1.4 Abbott Laboratories Revenue in Clinical Biomarkers Business (2015-2020))
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Agilent Technologies, Inc.
  • 11.2.1 Agilent Technologies, Inc. Company Details
  • 11.2.2 Agilent Technologies, Inc. Business Overview
  • 11.2.3 Agilent Technologies, Inc. Clinical Biomarkers Introduction
  • 11.2.4 Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.2.5 Agilent Technologies, Inc. Recent Development
• 11.3 ALCEDIAG
  • 11.3.1 ALCEDIAG Company Details
  • 11.3.2 ALCEDIAG Business Overview
  • 11.3.3 ALCEDIAG Clinical Biomarkers Introduction
  • 11.3.4 ALCEDIAG Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.3.5 ALCEDIAG Recent Development
• 11.4 Becton, Dickinson and Company
  • 11.4.1 Becton, Dickinson and Company Company Details
  • 11.4.2 Becton, Dickinson and Company Business Overview
  • 11.4.3 Becton, Dickinson and Company Clinical Biomarkers Introduction
  • 11.4.4 Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.4.5 Becton, Dickinson and Company Recent Development
• 11.5 bioMérieux S.A.
  • 11.5.1 bioMérieux S.A. Company Details
  • 11.5.2 bioMérieux S.A. Business Overview
  • 11.5.3 bioMérieux S.A. Clinical Biomarkers Introduction
  • 11.5.4 bioMérieux S.A. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.5.5 bioMérieux S.A. Recent Development
• 11.6 Bio-Rad Laboratories, Inc.
  • 11.6.1 Bio-Rad Laboratories, Inc. Company Details
  • 11.6.2 Bio-Rad Laboratories, Inc. Business Overview
  • 11.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Introduction
  • 11.6.4 Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.6.5 Bio-Rad Laboratories, Inc. Recent Development
• 11.7 CENTOGENE N.V.
  • 11.7.1 CENTOGENE N.V. Company Details
  • 11.7.2 CENTOGENE N.V. Business Overview
  • 11.7.3 CENTOGENE N.V. Clinical Biomarkers Introduction
  • 11.7.4 CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.7.5 CENTOGENE N.V. Recent Development
• 11.8 F. Hoffmann-La Roche Ltd.
  • 11.8.1 F. Hoffmann-La Roche Ltd. Company Details
  • 11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
  • 11.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Introduction
  • 11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
• 11.9 Enzo Biochem Inc.
  • 11.9.1 Enzo Biochem Inc. Company Details
  • 11.9.2 Enzo Biochem Inc. Business Overview
  • 11.9.3 Enzo Biochem Inc. Clinical Biomarkers Introduction
  • 11.9.4 Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.9.5 Enzo Biochem Inc. Recent Development
• 11.10 Illumina, Inc.
  • 11.10.1 Illumina, Inc. Company Details
  • 11.10.2 Illumina, Inc. Business Overview
  • 11.10.3 Illumina, Inc. Clinical Biomarkers Introduction
  • 11.10.4 Illumina, Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 11.10.5 Illumina, Inc. Recent Development
• 11.11 Myriad Genetics, Inc.
  • 10.11.1 Myriad Genetics, Inc. Company Details
  • 10.11.2 Myriad Genetics, Inc. Business Overview
  • 10.11.3 Myriad Genetics, Inc. Clinical Biomarkers Introduction
  • 10.11.4 Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 10.11.5 Myriad Genetics, Inc. Recent Development
• 11.12 Quest Diagnostics Incorporated
  • 10.12.1 Quest Diagnostics Incorporated Company Details
  • 10.12.2 Quest Diagnostics Incorporated Business Overview
  • 10.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Introduction
  • 10.12.4 Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2015-2020)
  • 10.12.5 Quest Diagnostics Incorporated Recent Development
• 11.13 QIAGEN N.V.
  • 10.13.1 QIAGEN N.V. Company Details
  • 10.13.2 QIAGEN N.V. Business Overview
  • 10.13.3 QIAGEN N.V. Clinical Biomarkers Introduction
  • 10.13.4 QIAGEN N.V. Revenue in Clinical Biomarkers Business (2015-2020)
  • 10.13.5 QIAGEN N.V. Recent Development
• 11.14 Thermo Fisher Scientific Inc.
  • 10.14.1 Thermo Fisher Scientific Inc. Company Details
  • 10.14.2 Thermo Fisher Scientific Inc. Business Overview
  • 10.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Introduction
  • 10.14.4 Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2015-2020)
  • 10.14.5 Thermo Fisher Scientific Inc. Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Clinical Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers

Market segment by Application, split into
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others

Based on regional and country-level analysis, the Clinical Biomarkers market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Clinical Biomarkers market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott Laboratories
Agilent Technologies, Inc.
ALCEDIAG
Becton, Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd.
Enzo Biochem Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.